Group 1 - The core point of the article is that Shanghai Silicon Industry Group announced a plan for a significant share reduction by the National Integrated Circuit Industry Investment Fund, which currently holds 5.67 billion shares, representing 20.64% of the company [1] - The investment fund intends to reduce its holdings by up to approximately 54.94 million shares, which is not more than 2% of the total share capital, within three months after the announcement [1] - As of the report, the market capitalization of Shanghai Silicon Industry is 66.2 billion yuan [1] Group 2 - The article also highlights the booming secondary market for biopharmaceuticals in China, with overseas licensing deals reaching 80 billion USD this year [1] - There is a contrast noted between the hot secondary market and the cooling fundraising environment in the primary market for biopharmaceuticals [1]
沪硅产业:产业投资基金计划减持公司股份不超过约5494万股